On the other hand, chronic cases with glomerulosclerosis and interstitial fibrosis were treated with angiotensin converting enzyme inhibitor (ACEI)/angiotensin receptor blocker (ARB) or calcium channel blocker (CCB), which were used significantly more in the NS group (Table 4). The gene discussed is ACE; the disease is glomerulosclerosis.